Skip to Content
· Dermal Fillers
SKU 10009

AesPlla

In stock
Volume
1 x 365 mg
Laboratory
Oreon Life Science Co., Ltd.
Origin
South Korea
Indication
Gradual facial volume restoration via collagen stimulation
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

aesPlla is a poly-L-lactic acid dermal filler supplied as a powder, developed to fill lost volume by stimulating collagenesis rather than by adding gel. It is indicated for use in immune-competent people as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Each vial contains 365 mg of PLLA in a 5 ml vial, and is reconstituted before use with water for injection and lidocaine. PLLA has been used for more than 20 years in medical devices, including dissolvable stitches, and because aesPlla is made of synthetic materials there is no need for allergy testing prior to treatment. It is CE marked and approved by the Korean Ministry of Food and Drug Safety.

Key Benefits of AesPlla

  • Restores volume by stimulating the patient's own collagen rather than by adding gel
  • Collagen generated in response to the implant lasts more than 2 years
  • PLLA is biodegradable and has been used in medical devices, including dissolvable stitches, for more than 20 years
  • Synthetic composition, so no allergy testing is required before treatment
  • Natural result that appears gradually
  • Short treatment time and quick recovery, with less downtime before returning to daily life
  • Costs less than surgical alternatives
  • CE marked and approved by the Korean MFDS
Key Information
Brand AESPLLA
Manufacturer Oreon Life Science Co., Ltd.
Country of Origin South Korea
Certification CE marked. Also approved by the Korean Ministry of Food and Drug Safety (MFDS).
Ingredients Poly-L-lactic acid (PLLA) powder, 365 mg per vial. Reconstituted before use with water for injection and lidocaine.
Volume / Size 5 ml
Packaging 365 mg x 1 vial (5 ml)
Use Type For professional use - injectable collagen stimulator, administered by licensed practitioners only
Injection Depth Injected into the subcutaneous layer of the skin once diluted. The stated indication refers to deep dermal placement.
Protocol / Duration Indicated as a single regimen. The collagen generated in response to the implant lasts more than 2 years, after which the PLLA particles are biodegraded.

Indications and Professional Use

Main indications

  • Correction of shallow to deep nasolabial fold contour deficiencies
  • Correction of other facial wrinkles
  • Volume restoration through collagen regeneration

Professional use

For professional use. aesPlla is administered by licensed practitioners trained in biostimulatory injectable technique, and is not for retail sale or self-administration. It is supplied as a powder and must be reconstituted before use: the working solution is aesPlla plus water for injection and lidocaine. The diluted product is injected into the subcutaneous layer of the skin. Because the correction develops through collagen generation over weeks rather than appearing at the time of treatment, the practitioner should set patient expectations accordingly.

Treatment areas

  • Facial wrinkles and folds
  • Nasolabial folds

Patient profile

Indicated for use in immune-competent people, as assessed by the treating practitioner. Because aesPlla is comprised of synthetic materials, there is no need for allergy testing prior to treatment. It is intended as a single regimen for shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.

How AesPlla Works

Diluted aesPlla is injected into the subcutaneous layer of the skin. The first improvement in wrinkles comes from the water for injection carrying the diluted powder, but within a few days that water is absorbed and only the PLLA particles remain. New cells then gather around those particles and fibroblast numbers increase; the increased fibroblasts stimulate collagen generation, which is what improves the skin folds. The collagen generated in this way lasts more than 2 years, while the aesPlla particles themselves are biodegraded. Because the result is built from the patient's own collagen rather than from an implanted gel, it appears gradually rather than immediately.

Why Order From Allpara

Allpara offers genuine, verified AESPLLA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does aesPlla differ from a hyaluronic acid filler?

Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.

How is aesPlla prepared before treatment?

It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.

Does aesPlla require allergy testing before treatment?

No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.

Where can clinics buy aesPlla?

ALLPARA supplies aesPlla to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
AESPLLA
Laboratory
Oreon Life Science Co., Ltd.
SKU
10009
Format
1 x 365 mg
Origin
South Korea
Indication
Gradual facial volume restoration via collagen stimulation
Use
Professional / clinical biostimulatory injection
Treatment areas
/ Product details

The full file

aesPlla is a poly-L-lactic acid dermal filler supplied as a powder, developed to fill lost volume by stimulating collagenesis rather than by adding gel. It is indicated for use in immune-competent people as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Each vial contains 365 mg of PLLA in a 5 ml vial, and is reconstituted before use with water for injection and lidocaine. PLLA has been used for more than 20 years in medical devices, including dissolvable stitches, and because aesPlla is made of synthetic materials there is no need for allergy testing prior to treatment. It is CE marked and approved by the Korean Ministry of Food and Drug Safety.

Oreon Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does aesPlla differ from a hyaluronic acid filler?

Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.

How is aesPlla prepared before treatment?

It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.

Does aesPlla require allergy testing before treatment?

No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.

Where can clinics buy aesPlla?

ALLPARA supplies aesPlla to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.

/ Quick answers

Everything a buyer asks first

How does aesPlla differ from a hyaluronic acid filler?
Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.
How is aesPlla prepared before treatment?
It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.
Does aesPlla require allergy testing before treatment?
No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.
/ FAQ

Frequently asked

Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.
It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.
No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.
ALLPARA supplies aesPlla to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.

More from Oreon Life Science

View laboratory

Clinic alternatives

All products

AesPlla

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

aesPlla is a poly-L-lactic acid dermal filler supplied as a powder, developed to fill lost volume by stimulating collagenesis rather than by adding gel. It is indicated for use in immune-competent people as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Each vial contains 365 mg of PLLA in a 5 ml vial, and is reconstituted before use with water for injection and lidocaine. PLLA has been used for more than 20 years in medical devices, including dissolvable stitches, and because aesPlla is made of synthetic materials there is no need for allergy testing prior to treatment. It is CE marked and approved by the Korean Ministry of Food and Drug Safety.

Key Benefits of AesPlla

  • Restores volume by stimulating the patient's own collagen rather than by adding gel
  • Collagen generated in response to the implant lasts more than 2 years
  • PLLA is biodegradable and has been used in medical devices, including dissolvable stitches, for more than 20 years
  • Synthetic composition, so no allergy testing is required before treatment
  • Natural result that appears gradually
  • Short treatment time and quick recovery, with less downtime before returning to daily life
  • Costs less than surgical alternatives
  • CE marked and approved by the Korean MFDS
Key Information
Brand AESPLLA
Manufacturer Oreon Life Science Co., Ltd.
Country of Origin South Korea
Certification CE marked. Also approved by the Korean Ministry of Food and Drug Safety (MFDS).
Ingredients Poly-L-lactic acid (PLLA) powder, 365 mg per vial. Reconstituted before use with water for injection and lidocaine.
Volume / Size 5 ml
Packaging 365 mg x 1 vial (5 ml)
Use Type For professional use - injectable collagen stimulator, administered by licensed practitioners only
Injection Depth Injected into the subcutaneous layer of the skin once diluted. The stated indication refers to deep dermal placement.
Protocol / Duration Indicated as a single regimen. The collagen generated in response to the implant lasts more than 2 years, after which the PLLA particles are biodegraded.

Indications and Professional Use

Main indications

  • Correction of shallow to deep nasolabial fold contour deficiencies
  • Correction of other facial wrinkles
  • Volume restoration through collagen regeneration

Professional use

For professional use. aesPlla is administered by licensed practitioners trained in biostimulatory injectable technique, and is not for retail sale or self-administration. It is supplied as a powder and must be reconstituted before use: the working solution is aesPlla plus water for injection and lidocaine. The diluted product is injected into the subcutaneous layer of the skin. Because the correction develops through collagen generation over weeks rather than appearing at the time of treatment, the practitioner should set patient expectations accordingly.

Treatment areas

  • Facial wrinkles and folds
  • Nasolabial folds

Patient profile

Indicated for use in immune-competent people, as assessed by the treating practitioner. Because aesPlla is comprised of synthetic materials, there is no need for allergy testing prior to treatment. It is intended as a single regimen for shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.

How AesPlla Works

Diluted aesPlla is injected into the subcutaneous layer of the skin. The first improvement in wrinkles comes from the water for injection carrying the diluted powder, but within a few days that water is absorbed and only the PLLA particles remain. New cells then gather around those particles and fibroblast numbers increase; the increased fibroblasts stimulate collagen generation, which is what improves the skin folds. The collagen generated in this way lasts more than 2 years, while the aesPlla particles themselves are biodegraded. Because the result is built from the patient's own collagen rather than from an implanted gel, it appears gradually rather than immediately.

Why Order From Allpara

Allpara offers genuine, verified AESPLLA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does aesPlla differ from a hyaluronic acid filler?

Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.

How is aesPlla prepared before treatment?

It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.

Does aesPlla require allergy testing before treatment?

No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.

Where can clinics buy aesPlla?

ALLPARA supplies aesPlla to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.

More from Oreon Life Science

View laboratory →

aesPlla is a poly-L-lactic acid dermal filler supplied as a powder, developed to fill lost volume by stimulating collagenesis rather than by adding gel. It is indicated for use in immune-competent people as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. Each vial contains 365 mg of PLLA in a 5 ml vial, and is reconstituted before use with water for injection and lidocaine. PLLA has been used for more than 20 years in medical devices, including dissolvable stitches, and because aesPlla is made of synthetic materials there is no need for allergy testing prior to treatment. It is CE marked and approved by the Korean Ministry of Food and Drug Safety.

Oreon Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does aesPlla differ from a hyaluronic acid filler?

Mechanism and timing. A hyaluronic acid filler adds volume the moment it is placed. aesPlla is a poly-L-lactic acid powder that works by stimulating collagenesis: the initial change comes from the dilution fluid, which is absorbed within a few days, after which fibroblasts gather around the remaining PLLA particles and generate collagen. The result therefore appears gradually.

How is aesPlla prepared before treatment?

It is supplied as a powder in a 365 mg vial and reconstituted before use. The working solution is aesPlla combined with water for injection and lidocaine.

Does aesPlla require allergy testing before treatment?

No. aesPlla is comprised of synthetic materials, so no allergy testing is needed prior to treatment.

Where can clinics buy aesPlla?

ALLPARA supplies aesPlla to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.